Abstract
Health sector reforms since 1989 have transformed Vietnam’s healthcare system from a publicly funded and provided healthcare system to public–private mix. With the shift toward a market economy, Vietnam has introduced several market-oriented measures including the introduction of user fees, legalization of private pharmacy and medical practices, and liberalization of the production and sale of pharmaceuticals. Private pharmacies have become the dominant medicines supplier in the market. At the same time, the provision of free medicines dispensed through the public health system was discontinued. Spending on medicines, user fees, and increased autonomy for health facilities and healthcare providers led to substantial increases in out-of-pocket health expenditure. Because of high medicine prices, poor quality of medicines, irrational selection and use of medicines, unsustainable pharmaceutical production and distribution systems, and a lack of a financial support system for drug procurement, access to the right medicines at the time people need them remains a major challenge for the majority of the population.
A number of legislative and regulatory reforms have been introduced to address the side effects of the market economy on access to essential medicines. The initiatives, however, have not been able to keep up with the rapid changes in the health and pharmaceutical sectors. Furthermore, the provisions were not routinely monitored or effectively enforced.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Vietnam Dong: Vietnamese currency.
References
Bloor, K., & Freemantle, N. (1996). Fortnightly Review: lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. BMJ, 312(7045), 1525–1527.
BMI. (2009). Vietnam pharmaceuticals & healthcare report Q3 2009. London: Business Monitor International Ltd.
BMI Research (2015). Vietnam pharmaceuticals & healthcare report. BMI. http://store.bmiresearch.com/vietnam-pharmaceuticals-healthcare-report.html. Accessed 17 Dec 2015.
Bá»™ Tà i chÃnh (2004). Giá thuốc tăng 100–400% -Vì sao? Bá»™ Tà i ChÃnh. http://www.mof.gov.vn/Default.aspx?tabid=612&ItemID=14452. Accessed 22 Nov 2006.
Cao, Q.M. (2008). Pharmaceutical industry development, supply demand balancing solutions to stabilize the Vietnam pharmaceutical market. Papers prepared for Pharmaceutical sector conference 2008. Hanoi :Ministry of Health.
Chalker, J. (1995). Vietnam: profit and loss in health care. World Health Forum, 16, 194–195.
Chalker, J., Chuc, N. T. K., Falkenberg, T., Do, N. T., & Tomson, G. (2000). STD management by private pharmacies in Hanoi: practice and knowledge of drug sellers. Sexually Transmitted Infections, 76, 299–302.
Chalker, J., Ratanawijitrasin, S., Chuc, N. T. K., Petzold, M., & Tomson, G. (2005). Effectiveness of a multi-component intervention on dispensing practices at private pharmacies in Vietnam and Thailand–a randomized controlled trial. Social Science & Medicine, 60(1), 131–141 doi:S0277953604001996 [pii]. doi:10.1016/j.socscimed.2004.04.019.
Chuc, N. T. K. (2002). Towards good pharmacy practice in Hanoi: a multi-intervention study in private sector. Stockholm: Karolineska Institutet.
Chuc, N. T. K., Larsson, M., Do, N. T., Diwan, V. K., Tomson, G., & Falkenberg, T. (2002). Improving private pharmacy practice: a multi-intervention experiment in Hanoi ,Vietnam. Journal of Clinical Epidemiology, 55, 1148–1155.
Chuc, N. T. K., Larsson, M., Falkenberg, T., Do, N. T., Binh, N. T., & Tomson, G. (2001). Management of childhood acute respiratory infections at private pharmacies in Vietnam. The Annals of Pharmacotherapy, 35, 1283–1288.
Chuc, N. T. K., & Tomson, G. (1999). "Doi moi" and private pharmacies: a case study on dispensing and financing issues in Hanoi, Vietnam. European Journal of Clinical Pharmacology, 55, 325–333.
Dat, D. V., Binns, C. W., & Truyen, L. V. (1997). Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Tropical Medicine & International Health, 2(12), 1133–1139.
DAV. (2009). Report on Vietnam pharmaceutical sector 2008 and planning for 2009. National Pharmaceutical Sector Conference 2008. Hanoi: Drug Administration of Vietnam.
DAV. (2012). Implementation of GPP in Vietnam: achievements, difficulties and orientation in the forthcoming time. The role of pharmacies in public health care in Vietnam. Hanoi: Drug Administration of Vietnam.
Falkenberg, T., Binh, N. T., Larsson, M., Do, N. T., & Tomson, G. (2000). Pharmaceutical sector in transition-a cross sectional study in Vietnam. Southeast Asian Journal of Tropical Medicine and Public Health, 31(3), 590–597.
Gertler, P., & Litvack, J. (1998). Access to healthcare during transition: the role of the private sector in Vietnam. In D. Dollar, P. Glewwe, & J. I. Livack (Eds.), Household welfare and Vietnam's transition (pp. 235–256). Washington, DC: The World Bank.
Giang, K., & Allebeck, P. (2003). Self-reported illness and use of health services in a rural district of Vietnam: findings from an epidemiological field laboratory. Scandinavian Journal of Public Health, 31(Suppl.62), 52–58.
Gill, P., Freemantle, N., Bero, L., Haaijer Ruskamp, F. M., Markela, M., & Barjesteh, K. (1996). GPs' prescribing behaviour may be affected by drug promotion. BMJ, 313, 367.
Government of Vietnam. (1996a). Decision No 547/TTg on 13 Aug 1996 of the Prime Minister on the establishment of the Drug Administration of Vietnam under the Ministry of Health, Hanoi.
Government of Vietnam. (1996b). Resolution No. 37-CP of the Government on strategic orientations for public health care and protection in the 1996–2000 period and national drug policy. Hanoi.
GSO. (2009a). Average consumer price index. Gold and USD price index. General Statistics Office of Vietnam. http://www.gso.gov.vn/default_en.aspx?tabid=472&idmid=3&ItemID=7653. Accessed 16 Jan 2009.
GSO. (2009b). Number of health establishments by management level. General Statistics Office of Vietnam. http://www.gso.gov.vn/default_en.aspx?tabid=474&idmid=3&ItemID=7747. Accessed 11 May 2009.
Hoa, N. Q., Ohman, A., Lundborg, C. S., & Chuc, N. T. K. (2007). Drug use and health-seeking behavior for childhood illness in Vietnam - A qualitative study. Health Policy, 82, 320–329.
Larsson, M. (2003). Antibiotic use and resistance, Assessing and improving utilisation and provision of antibiotics and other drugs in Vietnam. Stockholm: Sciences Karolinska Institutet.
Lieberman, S.S., Capuno, J.J. & Hoang, V.M. (2005). Decentralizing health: lessons from Indonesia, the Philippines, and Vietnam. World Bank. http://siteresources.worldbank.org/INTEAPDECEN/Resources/Chapter-8.pdf. Accessed 12 Dec 2010.
Lipton, H., & Bird, J. (1993). Drug utilization review in ambulatory settings: state of the science and directions for outcomes research. Medical Care, 31, 1069–1082.
Lu, Y., Hernandez, P., Abegunde, D., & Edejer, T. (2011). The World Medicines Situation 2011 - Medicine expenditures. World Health Organization. http://www.who.int/nha/docs/world_medicine_situation.pdf. Accessed 02 Jan 2013.
Mac, T. L., Le, V. T., Vu, A. N., Preux, P. M., & Ratsimbazafy, V. (2006). AEDs availability and professional practices in delivery outlets in a city center in southern Vietnam. Epilepsia, 47(2), 330–334. doi:10.1111/j.1528-1167.2006.00425.x.
Mao, W., Vu, H., Xie, Z., Chen, W., & Tang, S. (2015). Systematic review on irrational use of medicines in China and Vietnam. PloS One, 10(3), e0117710. doi:10.1371/journal.pone.0117710.
MHBS. (2010). Report on the pharmaceutical sector analysis. Hanoi: MHB Securities.
Minh, P. D., Huong, D. T., Byrkit, R., & Murray, M. (2013). Strengthening pharmacy practice in vietnam: findings of a training intervention study. Tropical Medicine & International Health : TM & IH, 18(4), 426–434. doi:10.1111/tmi.12062.
MOH of Vietnam (2006). Circular 06/2006/TT-BYT of 16 May 2006 guiding the import and export of drugs and cosmetics. Hanoi : Ministry of Health of Vietnam.
MOH of Vietnam (2009). Circular No. 22/2009/TT-BYT of 24 November 2009 on guiding medicine registration. Hanoi: Ministry of Health of Vietnam.
MOH of Vietnam (2011). Circular No 31/2011/TT-BYT on 11 July 2011 of Ministry of Health issuing and guiding the implementation of the schedule of main medicines used in health facilities, which are reimbursable by Public Health Insurance. 31/2011/TT-BYT. Hanoi.
MOH of Vietnam (2013). United Proposal of National Medicines Policy in the period up to 2020 and the vision by 2030. Hanoi: Ministry of Health of Vietnam.
MOH of Vietnam, Health Partnership Group. (2008). Joint annual health review 2008: health financing in Vietnam. Hanoi: Ministry of Health of Vietnam.
Nguyen, A. T., Knight, R., Mant, A., Cao, M. Q., & Auton, M. (2009). Medicine prices, availability, and affordability in Vietnam. Southern Medical Review, 2(2), 2–9.
Nguyen, A. T., Knight, R., Mant, A., Cao, Q. M., & Brooks, G. (2010). Medicine pricing policies: lessons from Vietnam. Southern Medical Review, 3(2), 12–19.
Nguyen, T. A. (2011). Medicine prices and pricing policies in Vietnam. School of Public Health and Community Medicine. Sydney: The University of New South Wales.
Nguyen, T. A., Hassali, M. A., & McLachlan, A. (2013). Generic medicines policies in the Asia Pacific region: ways forward. WHO South-East Asia Journal of Public Health, 2(1), 72–74.
Nguyen, T. A., & Roughead, E. E. (2015). Pharmaceutical Pricing Policies in Vietnam. InBarba Z-U-D (ed) Pharmaceutical Prices in the 21st Century (1st ed., pp. 321–342). Switzerland: Springer International Publishing. doi:10.1007/978-3-319-12169-7_18.
Quagliarello, A. B., Parry, C. M., Hien, T. T., & Farrar, J. J. (2003). Factors associated with carriage of penicillin-resistant Streptococcus pneumoniae among Vietnamese children: a rural-urban divide. Journal of Health, Population, and Nutrition, 21(4), 316–324.
Sepehri, A., Moshiri, S., Simpson, W., & Sarma, S. (2008). Taking account of context: how important are household characteristics in explaining adult health-seeking behaviour? The case of Vietnam. Health Policy and Planning, 23, 397–407.
Smith, F. (2009). The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharmacy world & science : PWS, 31(3), 351–361. doi:10.1007/s11096-009-9294-z.
Somanathan, A., Dao, H. L., & Tran, T. V. (2013). Integrating the Poor into Universal Health Coverage in Vietnam. Universal Health Coverage Studies Series (UNICO)-UNICO Studies (Vol. 24). Washington DC: The World Bank.
Sutters, C. A. (1990). The management of a hospital formulary. Journal of Clinical Pharmacy and Therapeutics, 15(1), 59–76.
Thanh Hải (2008). Lũng đoạn giá thuốc tại hơn 1000 nhà thuốc bệnh viện. http://laodong.com.vn/Home/Lung-doan-gia-thuoc-tai-hon-1000-nha-thuoc-benh-vien/20087/97241.laodong. Accessed 22 Dec 2008.
WHO-WPRO. (2013). Essential Medicines. WHO in the Western Pacific Region. http://www.wpro.who.int/vietnam/topics/essential_medicines/factsheet/en/index.html. Accessed 7 May 2013.
WHO. (2000). The World Health Report 2000: health systems, improving performance. Geneva: World Health Organization.
WHO. (2007). Country Cooperation Strategy: Vietnam 2007–2011. World Health Organization. http://www.wpro.who.int/NR/rdonlyres/D3DCF855-DF91-441B-9EFE-BF286364D02A/0/CCS20072011.pdf. Accessed 5 May 2009.
WHO. (2008). National health account series. World Health Organization. http://www.who.int/nha/country/vnm.pdf. Accessed 5 Jan 2009.
WHO. (2010). National health account series. World Health Organization. http://www.who.int/nha/country/vnm.pdf. Accessed 19 Dec 2010.
Witter, S. (1996). ‘Doi Moi’ and health: the effect of economic reforms on the health system in Vietnam. International Journal of Health Planning and Management, 11, 159–172.
Wolffers, I. (1995). The role of pharmaceuticals in the privatization process in Vietnam's health-care system. Social Science & Medicine, 41(9), 1325–1332.
Wondemagegnehu, E (1999). Counterfeit and Substandard drugs in Myanmar and Viet Nam - Report of a study carried out in cooperation with the Governments of Myanmar and Viet Nam. Essential drugs and other medicines, Geneva :WHO
World Bank (2007). Vietnam development report 2008: social protection. World Bank. http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2008/06/04/000333038_20080604015001/Rendered/PDF/436530WP0REVIS1ction1final01PUBLIC1.pdf. Accessed 21 Feb 2009.
World Bank, SIDA, AusAID, Royal Netherlands Embassy, MOH. (2001). Growing healthy: a Review of Vietnam's Health Sector. Hanoi: Ministry of Health.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Nguyen, T.A., Vitry, A., Roughead, E.E. (2017). Pharmaceutical Policy in Vietnam. In: Babar, ZUD. (eds) Pharmaceutical Policy in Countries with Developing Healthcare Systems. Adis, Cham. https://doi.org/10.1007/978-3-319-51673-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-51673-8_5
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-51672-1
Online ISBN: 978-3-319-51673-8
eBook Packages: MedicineMedicine (R0)